Necrotizing fasciitis historical perspective: Difference between revisions
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
*Guiliano and colleagues divided the necrotizing fasciitis into type I and type II.<ref name="pmid19258208">{{cite journal| author=Krieg A, Röhrborn A, Schulte Am Esch J, Schubert D, Poll LW, Ohmann C et al.| title=Necrotizing fasciitis: microbiological characteristics and predictors of postoperative outcome. | journal=Eur J Med Res | year= 2009 | volume= 14 | issue= 1 | pages= 30-6 | pmid=19258208 | doi= | pmc=3352202 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19258208 }} </ref> | *Guiliano and colleagues divided the necrotizing fasciitis into type I and type II.<ref name="pmid19258208">{{cite journal| author=Krieg A, Röhrborn A, Schulte Am Esch J, Schubert D, Poll LW, Ohmann C et al.| title=Necrotizing fasciitis: microbiological characteristics and predictors of postoperative outcome. | journal=Eur J Med Res | year= 2009 | volume= 14 | issue= 1 | pages= 30-6 | pmid=19258208 | doi= | pmc=3352202 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19258208 }} </ref> | ||
*In 1989, Stevens and colleagues were the first to characterize unique clinical characteristics associated with GASNF.<ref name="pmid8903167">{{cite journal| author=Stevens DL| title=Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. | journal=Emerg Infect Dis | year= 1995 | volume= 1 | issue= 3 | pages= 69-78 | pmid=8903167 | doi=10.3201/eid0103.950301 | pmc=2626872 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8903167 }} </ref> | *In 1989, Stevens and colleagues were the first to characterize unique clinical characteristics associated with GASNF.<ref name="pmid8903167">{{cite journal| author=Stevens DL| title=Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. | journal=Emerg Infect Dis | year= 1995 | volume= 1 | issue= 3 | pages= 69-78 | pmid=8903167 | doi=10.3201/eid0103.950301 | pmc=2626872 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8903167 }} </ref> | ||
*The soft tissue infections were first classified as either local or spreading by Smith et al<ref name="pmid9003684">{{cite journal| author=Smith AJ, Daniels T, Bohnen JM| title=Soft tissue infections and the diabetic foot. | journal=Am J Surg | year= 1996 | volume= 172 | issue= 6A | pages= 7S-12S | pmid=9003684 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9003684 }} </ref> | |||
*The soft tissue infections are classified into either necrotizing or non necrotizing by Lewis and further subdivided these infections into focal or diffuse.<ref name="pmid9451929">{{cite journal| author=Lewis RT| title=Soft tissue infections. | journal=World J Surg | year= 1998 | volume= 22 | issue= 2 | pages= 146-51 | pmid=9451929 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9451929 }} </ref> | |||
==References== | ==References== |
Revision as of 20:21, 6 September 2016
Necrotizing fasciitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Necrotizing fasciitis historical perspective On the Web |
American Roentgen Ray Society Images of Necrotizing fasciitis historical perspective |
Risk calculators and risk factors for Necrotizing fasciitis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
Historical Perspective
- Necrotizing fasciitis was first described by Hippocrates in the fifth century B.C. as the complication of erysipelas.[1][2]
- It was first described as "Hospital gangrene" during civil war by confederate army surgeon Joseph Jones.
- In 1883, Necrotizing fasciitis was first described in a specific body region by Fournier.
- Meleney reported a series of 20 patients in 1924 as having hemolytic streptococcal gangrene, later called meleney's gangrene.
- The association between bacterial infection and necrotizing fasciitis was made in 1918.
- In 1952, the disease was named as necrotizing fasciitis by Wilson.
- Necrotizing fasciitis of perineum was described in 1883 by the French physician, Jean Alfred Fournier.
- Guiliano and colleagues divided the necrotizing fasciitis into type I and type II.[3]
- In 1989, Stevens and colleagues were the first to characterize unique clinical characteristics associated with GASNF.[4]
- The soft tissue infections were first classified as either local or spreading by Smith et al[5]
- The soft tissue infections are classified into either necrotizing or non necrotizing by Lewis and further subdivided these infections into focal or diffuse.[6]
References
- ↑ Wasfy AA, Shoeb S, El-Mashad A, El-Ebrashy N, Higazi A, Gaber A; et al. (1978). "Detection of anaerobic respiratory bacteria with a new therapeutic approach". J Egypt Med Assoc. 61 (11–12): 757–61. PMID 556077.
- ↑ Korzekwa P, Poplicha T (1992). "[A rare case of coexistence of aneurysm of the abdominal aorta and sigmoid neoplasm]". Wiad Lek. 45 (1–2): 62–3. PMID 1295242.
- ↑ Krieg A, Röhrborn A, Schulte Am Esch J, Schubert D, Poll LW, Ohmann C; et al. (2009). "Necrotizing fasciitis: microbiological characteristics and predictors of postoperative outcome". Eur J Med Res. 14 (1): 30–6. PMC 3352202. PMID 19258208.
- ↑ Stevens DL (1995). "Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment". Emerg Infect Dis. 1 (3): 69–78. doi:10.3201/eid0103.950301. PMC 2626872. PMID 8903167.
- ↑ Smith AJ, Daniels T, Bohnen JM (1996). "Soft tissue infections and the diabetic foot". Am J Surg. 172 (6A): 7S–12S. PMID 9003684.
- ↑ Lewis RT (1998). "Soft tissue infections". World J Surg. 22 (2): 146–51. PMID 9451929.